Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Queensland Health
Boehringer Ingelheim
Express Scripts
Harvard Business School
QuintilesIMS
Dow
Chinese Patent Office
US Army

Generated: September 22, 2018

DrugPatentWatch Database Preview

Aurobindo Pharma Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for AUROBINDO PHARMA LTD, and what generic and branded alternatives to AUROBINDO PHARMA LTD drugs are available?

AUROBINDO PHARMA LTD has two hundred and sixty approved drugs.

There are twenty-eight tentative approvals on AUROBINDO PHARMA LTD drugs.

Summary for Aurobindo Pharma Ltd

Drugs and US Patents for Aurobindo Pharma Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd PARICALCITOL paricalcitol CAPSULE;ORAL 207672-001 Jan 14, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd OLANZAPINE olanzapine TABLET;ORAL 202050-006 Apr 23, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd ATAZANAVIR SULFATE atazanavir sulfate CAPSULE;ORAL 204806-004 Jun 25, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd VALSARTAN AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; valsartan TABLET;ORAL 202519-001 Mar 21, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd OMEPRAZOLE omeprazole CAPSULE, DELAYED REL PELLETS;ORAL 203270-001 Aug 19, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd ABACAVIR SULFATE AND LAMIVUDINE abacavir sulfate; lamivudine TABLET;ORAL 206151-001 Mar 28, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for AUROBINDO PHARMA LTD drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
Queensland Health
Fuji
Cerilliant
Harvard Business School
QuintilesIMS
McKesson
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.